AZIN1 RNA Editing Alters Protein Interactions, Leading to Nuclear Translocation and Worse Outcomes in Prostate Cancer

After comparison of wild-type Antizyme Inhibitor 1 (AZIN1) and edited AZIN1 (edAZIN1), investigators reported differential binding of edAZIN1 to a small set of proteins.